Uncategorized Archives - Geneseeq Technology Inc. | A Precision Oncology Company

August 29, 2023

GENESEEQ TO SHARE EIGHT COLLABORATED STUDIES AT WCLC 2023

August 22, 2023

Geneseeq Gains CE Marks for NGS-based Test Kits for Solid Tumors and Hematological Cancer

May 25, 2023

GENESEEQ TO SHOWCASE NEW FINDINGS AT ASCO 2023

May 16, 2023

Geneseeq published new research on the clinical use of circulating-free DNA fragmentomic in monitoring minimal residual disease for patients with non-small-cell lung cancer

April 13, 2023

Geneseeq co-publish with UHN on using ctDNA as a prognostic biomarker for immunotherapy

April 11, 2023

Geneseeq to Present 13 Posters at AACR 2023

November 15, 2022

Geneseeq Publishes Promising Early Lung Cancer Detection Results in AJRCCM

August 3, 2022

GENESEEQ AND COLLABORATORS SHARE NEW FINDINGS AT WORLD CONFERENCE ON LUNG CANCER 2022

July 19, 2022

Geneseeq, Brazilian Hospital Partner on Co-establishment of In-house NGS Lab

April 5, 2022

Geneseeq Presents 9 Posters at AACR 2022